A Randomized, Double-Blind, Placebo-Controlled, Clinical Evaluation of the Efficacy, Safety and Tolerability of Neramexane in Patients With Subjective Tinnitus
Phase of Trial: Phase III
Latest Information Update: 12 Feb 2016
At a glance
- Drugs Neramexane (Primary)
- Indications Tinnitus
- Focus Registrational; Therapeutic Use
- Acronyms EASE
- Sponsors Merz Pharmaceuticals GmbH
- 10 Jun 2014 New trial record
- 25 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 02 Sep 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.